Custom mRNA vaccine aims to stop liver Cancer's return
Disease control
Recruiting now
This study is testing a personalized mRNA vaccine designed to train the immune system to recognize and attack a patient's specific liver cancer cells. The vaccine is given along with an immunotherapy drug to patients who have recently had their liver tumors surgically removed. Th…
Phase: PHASE1, PHASE2 • Sponsor: Yinghua Xu • Aim: Disease control
Last updated Apr 21, 2026 12:43 UTC